The overall incidence of Down's syndrome or Trisomy 21 is 1 in 800 births. The risk increases with age and reaches to 1 in 35 term births for women over 45 years of age. NIPT is iGenetic's unique offering for risk free detection of Down's syndrome and other aneuploidies.
iGenetic has developed a patented technology which is completely non invasive for pre-natal genetic screening without the need for Aminocentesis. Circulating fetal cells and fetal DNA in the mother’s blood are isolated and screened for chromosomal aneuploidies.
Non Invasive Pre Natal Test for screening of Chromosomal aneuploidies for 21,13, 18 and sex chromosomes, Thalassemia, Sickle Cell Anemia, Muscular Dystrophy
|FISH, Molecular Genetics, Next Generation Sequencing||10 days||20 ml Mother's blood in EDTA|
|Method||FISH, Molecular Genetics, Next Generation Sequencing|
|Sample required||20 ml Mother's blood in EDTA|
Please contact us by phone or email to schedule a test.